Skip to main content
Bonterra logo

Bonterra

Security and trust center evidence

Summary

Bonterra has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Ready. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, Bonterra is listed in the FedRAMP registry with a status of FedRAMP Ready, with A-LIGN Compliance and Security, Inc. dba A-LIGN named as auditor. As of 17 Sep 2026, Bonterra is listed in the EU-US Data Privacy Framework registry as Active across EU-US Certification, SW-US Certification, and UK Extension Certification, with the certification originally issued 30 Jun 2023 and an expiry date of 17 Oct 2026. As of 17 Sep 2026, this Data Privacy Framework listing is approaching its expiry date of 17 Oct 2026 and should be monitored for renewal. As of 17 Sep 2026, no public evidence found for SOC 2 for Bonterra. As of 17 Sep 2026, no public evidence found for HIPAA for Bonterra.

  • FedRAMP: listed in FedRAMP registry as 'FedRAMP Ready', auditor A-LIGN Compliance and Security, Inc. dba A-LIGN, as of 17 Sep 2026
  • EU-US Data Privacy Framework: listed in DPF registry as Active (EU-US, SW-US, UK Extension Certifications), issued 30 Jun 2023, expires 17 Oct 2026, as of 17 Sep 2026
  • SOC 2 and HIPAA: no public evidence found as of 17 Sep 2026

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among nonprofit and fundraising vendors

2verified rows

Category median 1, across 32 indexed nonprofit and fundraising vendors. Bonterra has more verified rows than 97 percent of them.

donor engagementimpact managementnonprofit softwaresocial goodvolunteer management

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Nonprofit and fundraising category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.